Background: Surgery is currently the most successful approach for difficult cases of vitiligo. The efficacy of epidermal surface removal (dermabrasion) is near 50%, and the efficacy of grafts is 70%.
Objective: To evaluate the efficacy and safety of a combined approach using dermabrasion and grafting for unresponsive vitiligo.
Patients And Methods: Eleven patients with stable vitiligo each underwent two different procedures on different body areas: transfer of melanocytes and epidermal cells obtained using the "sandpaper method" combined with dermabrasion of the receptor area or simple dermabrasion. Micropunch testing was used to evaluate the activity of vitiligo. Only patients without activity were treated. Subjects were followed for 3 months, and digital pictures were analyzed to estimate the percentage of repigmentation.
Results: Transfer delivered visible results in the first month, and dermabrasion showed results in the second month. The quality of pigmentation was superior with the transfer technique, especially in the short term, although at the end of treatment, both techniques showed similar results.
Conclusions: Transfer of melanocytes and keratinocytes with the sandpaper method is feasible, safe, and effective as treatment for stable vitiligo, although simple dermabrasion is as effective in the long term.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1524-4725.2010.01856.x | DOI Listing |
Arch Dermatol Res
January 2025
Dermatology and Venereology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
Both the surgical non-cultured melanocyte-keratinocyte transplant procedure (MKTP) and intradermal injection of 5-Fluorouracil (5-FU) are effective in the treatment of vitiligo. Intrablisters injection of MKTP was done in one study with better results than MKTP application after ablative CO2 laser of the reciepient area. However, intrablister injection of 5-FU was not done before.
View Article and Find Full Text PDFArch Dermatol Res
January 2025
Department of Physiotherapy, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, 210042, China.
Background: Previous studies have proven that 308-nm light-emitting diode(308-nm LED)and 308-nm excimer lamp(308-nm MEL) are effective in treating vitiligo, but there is a lack of comparison of their efficacy for facial lesions.
Objective: To evaluate and contrast the treatment success rates of 308-nm LED versus 308-nm excimer lamp in managing facial lesions among patients suffering from stable non-segmental vitiligo.
Methods: The enrolled 119 patients with 145 lesions were randomly assigned to receive 308-nm LED or 308-nm MEL for two months.
J Pharm Anal
November 2024
Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.
Vitiligo is an immune memory skin disease. T-cell factor 1 (TCF1) is essential for maintaining the memory T-cell pool. There is an urgent need to investigate the characteristics of peripheral memory T-cell profile and TCF1 T-cell frequencies in patients with vitiligo.
View Article and Find Full Text PDFBackground: Research on evaluating the efficacy of non-cultured epidermal cell suspension (NCECS) combined with excimer lamps for the treatment of vitiligo is currently unavailable. This research aims to evaluate the efficacy of this combination in treating vitiligo.
Methods: A prospective, controlled study was conducted from November 2021 to January 2024.
Dermatol Pract Concept
October 2024
Department of Dermatology, Venereology and Leprosy, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
Introduction: Dermoscopy is an important noninvasive tool that helps to determine the stability and activity of vitiligo. Various dermoscopic findings help classify the disease as stable or unstable. This is important for the management of the disease, as surgical management requires disease stability.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!